<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04563780</url>
  </required_header>
  <id_info>
    <org_study_id>99mTC thyroid scan in DTC</org_study_id>
    <nct_id>NCT04563780</nct_id>
  </id_info>
  <brief_title>The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer</brief_title>
  <official_title>The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the prognostic value of postoperative99mTc-pertechnetate&#xD;
      scanning in patients with DTC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of thyroid cancer in several affluent countries has markedly increased (1).&#xD;
      Although mortality from thyroid cancer has remained relatively low and stable or has steadily&#xD;
      declined in these and other countries (2).&#xD;
&#xD;
      Therefore, it is still important to identify markers for prognosis prediction and&#xD;
      decision-making before radioactive iodine therapy (RIT). Various factors have been reported&#xD;
      to be associated with the clinical outcome of RIT. These include preablative stimulated&#xD;
      thyroglobulin (ps- Tg), tumor size, extrathyroidal invasiveness, cervical lymph node&#xD;
      metastasis and TSH [3,4].&#xD;
&#xD;
      99mTc pertechnetate is a radiopharmaceutical used for thyroid scintigraphy. The photon energy&#xD;
      of 140kev is ideally suited for use with gamma camera. It has short half life of about&#xD;
      6-hoursand no particulate emissions. 99mTc-pertechnetate scintigraphy is a simple, economic&#xD;
      and RIT non-interfering technique to evaluate the volume of residual thyroid tissue(RTT). The&#xD;
      99m Tc-pertechnetate uptake of the thyroid bed can be used as a marker of RTT. Although&#xD;
      negative uptake doesn't indicate the absence of RTT, it could suggest a small volume. On the&#xD;
      other hand, positive uptake can be considered as a large volume of RTT. Several studies have&#xD;
      reported that patients with negative 99mTc-pertechnetate uptake have a much higher chance of&#xD;
      successful ablation[5, 6].&#xD;
&#xD;
      We hypothesized that negative 99mTc-pertechnetate scintigraphy is a significant predictor for&#xD;
      excellent response (ER) to RIT in American Thyroid Association 2015(ATA) low- and&#xD;
      intermediate risk DTC patient according to .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prognostic value of post thyroidectomy 99mTCpertechnetate thyroid scan in patient with differentiated thyroid cancer</measure>
    <time_frame>baseline</time_frame>
    <description>The prognostic value of post thyroidectomy 99mTCpertechnetate thyroid scan in patient with differentiated thyroid cancer</description>
  </primary_outcome>
  <enrollment type="Anticipated">113</enrollment>
  <condition>Differentiated Thyroid Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>99mTC pertechnetate thyroid scan</intervention_name>
    <description>Thyroid scintigraphy was performed just before RIT. 20 min after intravenous injection 99mTc-pertechnetate, anterior images of the neck were acquired using a scintillation camera equipped with low-energy high resolution collimator. Energy discrimination was provided with a 20% window that was centered on the 140 keV peak of 99mTc .</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patient underwent total thyroidectomy in low and intermediate risk will done thyroid&#xD;
        scan&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • This study will include pathologically proved DTC patients in low and intermediate&#xD;
             risk according to ATA who presented to nuclear medicine unit during the period from&#xD;
             2015 until the end of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • High risk patient according to ATA&#xD;
&#xD;
               -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Aya Khaled</last_name>
    <phone>01021427102</phone>
    <email>aayahkhaled@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aya Khaled Mahmoud</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aya Khaled</last_name>
      <phone>01021427102</phone>
      <email>aayahkhaled@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Waleed Diab, assist prof</last_name>
      <phone>01004242213</phone>
      <email>Drwaleedin2000@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, Ferretti S, Torrisi A, Falcini F, Zorzi M, Cirilli C, Mazzucco W, Magoni M, Collarile P, Pannozzo F, Caiazzo AL, Russo AG, Gili A, Caldarella A, Zanetti R, Michiara M, Mangone L, Filiberti RA, Fusco M, Gasparini F, Tagliabue G, Cesaraccio R, Tumino R, Gatti L, Tisano F, Piffer S, Sini GM, Mazzoleni G, Rosso S, Fanetti AC, Vaccarella S; for AIRTUM working group. The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012. Eur J Cancer. 2018 May;94:6-15. doi: 10.1016/j.ejca.2018.01.083. Epub 2018 Mar 20.</citation>
    <PMID>29502036</PMID>
  </reference>
  <reference>
    <citation>Li M, Brito JP, Vaccarella S. Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis. Thyroid. 2020 Jun;30(6):838-846. doi: 10.1089/thy.2019.0684. Epub 2020 Mar 2.</citation>
    <PMID>31964280</PMID>
  </reference>
  <reference>
    <citation>Liu N, Meng Z, Jia Q, Tan J, Zhang G, Zheng W, Wang R, Li X, Hu T, Upadhyaya A, Zhou P, Wang S. Multiple-factor analysis of the first radioactive iodine therapy in post-operative patients with differentiated thyroid cancer for achieving a disease-free status. Sci Rep. 2016 Oct 10;6:34915. doi: 10.1038/srep34915.</citation>
    <PMID>27721492</PMID>
  </reference>
  <reference>
    <citation>Jung JS, Lee SM, Kim SJ, Choi J, Han SW. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy. Nucl Med Commun. 2015 Jan;36(1):38-44. doi: 10.1097/MNM.0000000000000219.</citation>
    <PMID>25299469</PMID>
  </reference>
  <reference>
    <citation>Tsai CJ, Cheng CY, Shen DH, Kuo SJ, Wang LY, Lee CH, Wang JJ, Chang MC, Huang WS. Tc-99m imaging in thyroidectomized differentiated thyroid cancer patients immediately before I-131 treatment. Nucl Med Commun. 2016 Feb;37(2):182-7. doi: 10.1097/MNM.0000000000000426.</citation>
    <PMID>26626550</PMID>
  </reference>
  <reference>
    <citation>Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis. J Clin Oncol. 2016 Oct 20;34(30):3672-3679. doi: 10.1200/JCO.2016.67.7419.</citation>
    <PMID>27601555</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 21, 2020</study_first_submitted>
  <study_first_submitted_qc>September 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Aya Khaled Mahmoud</investigator_full_name>
    <investigator_title>resident doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sodium Pertechnetate Tc 99m</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

